82 results
Page 2 of 5
8-K
EX-2.1
d5jxe 5ea67
21 Dec 20
Entry into a Material Definitive Agreement
9:15pm
DEFA14A
EX-99.1
se2sq
21 Dec 20
Additional proxy soliciting materials
7:10am
8-K
EX-99.1
ofn4sy4 15pvp
21 Dec 20
Regulation FD Disclosure
7:04am
S-3ASR
EX-4.4
11g oa1wctvno
30 Apr 20
Automatic shelf registration
4:19pm
S-3ASR
EX-4.5
vve1vdv
30 Apr 20
Automatic shelf registration
4:19pm
S-3ASR
EX-1.2
ndghiu34
30 Apr 20
Automatic shelf registration
4:19pm
8-K
EX-99.1
osyf8z y75v9txl
9 Dec 19
Agios EstablishesProof-of-Concept for Mitapivat inNon-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results
4:02pm
8-K
EX-1.1
u0mpw0ab5h y1r168
8 Nov 19
Agios Announces Pricing of $256 Million Public Offering of Common Stock
4:57pm